Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : pharmaceutical labs (phlb) -- Ignore unavailable to you. Want to Upgrade?

To: Due Diligence who wrote (10)	8/14/1998 3:27:00 PM
From: Gator	Respond to of 227

PHARMACEUTICAL LABORATORIES Symbol : PHLB (OTC BB) Website : http:/www.phlb.com IR : George Baucom 1-800-856-7040 Email : phlb@interconnect.net Fully outstanding : 9.6 million (6.4 million restricted by rule 144) Public float : Approximately 3 million >>>>>>>> Thursday August 13, 4:34 pm Eastern Time Company Press Release Pharmaceutical Laboratories Inc. Reports Six Months Sales and Profits CORPUS CHRISTI, Texas--(BUSINESS WIRE)--Aug. 13, 1998-- Pharmaceutical Laboratories Inc. (OTC BB:PHLB) announced today revenues of $2.7 million for the six-month period ending June 30, 1998, gross profit of $1.6 million and net profit of $239,888. President and CEO Jerry McClure stated that ''the increase in sales and the positive response we received from the test-market conducted in over 100 outlets of a major U.S. superstore chain is placing the Company on a fast-track for growth in revenues.'' ''Sales in the first half of the year primarily consisted of regional market tests,'' McClure stated. ''We anticipate sales to increase in the second half of the year due to increased national distribution as a result of the successful market tests the Company has conducted.'' -0- 6 Months Ended 6/30/98 6/30/97 Gross Sales $2,697,833 $2,431,665 Net Profit 239,888 (186,256) EPS (6 months) $.03 ($.02) (unaudited) The Company recently completed a financing for $1 million. The funds will be used to build inventories, purchase equipment to further automate assembly lines and for advertising of the ''Liquid Solutions'' product line. Pharmaceutical Laboratories Inc., with offices in Arlington, Corpus Christi, and Harlingen, Texas, specializes in the development, manufacturing and marketing of liquid nutritional products. All products are manufactured on-site in the Company's state-of-the-art facilities. Pharmaceutical Laboratories Inc. is listed on the OTC Bulletin Board under the symbol PHLB. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1955; Statement in this news release looking forward in time involve risks and uncertainties, and actual results may be materially different. Factors that could cause actual results to differ include activity levels in the securities markets and other risk factors such as customer order rates, cancellations, late delivery of customer components, production delays, dependence upon certain customers, dependencies upon key executives, viability of quarterly results, single operating facility, competition, product liability risk, control by management, foreign currency fluctuation, and other risks detailed in the Company's applicable SEC filings. Contact: Pharmaceutical Laboratories Inc., Corpus Christi George Baucom, 800/856-7040 george@phlb.com